Statement from Acting Commissioner of Food and Drugs Norman E. "Ned" Sharpless, M.D., Peter Marks, M.D., Ph.D., director of the Center for Biologics Evaluation and Research, and Janet Woodcock, M.D., director of the Center for Drug Evaluation and Research on final guidance to help advance development of novel treatments for ALS
